Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Taiwan.
Press releases published on August 18, 2025
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
GlobeNewswire
·
August 18, 2025
The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE). The first WRAP North America patient was enrolled at Bluff City …
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
GlobeNewswire
·
August 18, 2025
STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an oral gamma secretase …
Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
GlobeNewswire
·
August 18, 2025
Live video webcast on Thursday, August 21st at 1:00 PM ET Register here THE WOODLANDS, TX, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision …
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
GlobeNewswire
·
August 18, 2025
STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an …
Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development
GlobeNewswire
·
August 18, 2025
PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development Itasca (IL), United States, August 18th, 2025 – Biocartis Group of Companies (“Biocartis”), an innovative molecular …
Elucent Medical Launches SmartSupport™ – A Smarter Standard in Surgical Support
GlobeNewswire
·
August 18, 2025
MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce the launch of SmartSupport™, a comprehensive, on-demand virtual support platform designed to enhance the procedural experience for clinicians using the EnVisio® In-Body …
Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine
GlobeNewswire
·
August 18, 2025
First-in-human trial of Capricor’s StealthX™ vaccine initiated under HHS’s Project NextGen Trial conducted and funded by the National Institute of Allergy and Infectious Diseases (NIAID) SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics ( …
Positron Emission Tomography Market to Capture a CAGR of 6.60% While Touching Approximately USD 4.44 Billion by 2034 – Report by Zion Market Research
GlobeNewswire
·
August 18, 2025
NEW YORK, USA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Positron Emission Tomography Market By Product Type (Partial ring PET scanner, Full ring PET scanner), By Detector Type (Lutetium …
Journey Medical Corporation to Present at the Emerging Growth Conference
GlobeNewswire
·
August 18, 2025
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company primarily focused on selling and marketing FDA-approved …
Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
August 18, 2025
August 18, 2025 Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Opportunity to be First Mover in $7.3Bn Addressable Market Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), ( …
Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy
GlobeNewswire
·
August 18, 2025
ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the appointment of its new …
Myriad Genetics Appoints Ben Wheeler Chief Financial Officer
GlobeNewswire
·
August 18, 2025
SALT LAKE CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Ben Wheeler has been promoted to Chief Financial Officer, effective August 16, …
NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
GlobeNewswire
·
August 18, 2025
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or …
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
GlobeNewswire
·
August 18, 2025
HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that the US Patent and Trademark Office has issued U.S. patent No. 12,357,584 B2 entitled “Composition and Method of Controlling Infectious Diseases with …
Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.
GlobeNewswire
·
August 18, 2025
Press Release Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Baar, Switzerland; August 14, 2025 …
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 18, 2025
NRx Drug Development Grant of expanded Fast Track Designation for NRX-100 from the FDA for all indications and types of depression and related disorders based on its potential to satisfy an unmet medical need. Represents an approximately 10-fold expansion …
Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases
GlobeNewswire
·
August 18, 2025
· Collaboration strengthens Boehringer’s pipeline in Eye Health. · Many patients with diabetic retinopathy (DR) continue to experience vision loss or treatment fatigue, underscoring an unmet need. · Melanocortin receptor agonists offer …
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority
GlobeNewswire
·
August 18, 2025
In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, cardiovascular events, and total health care costs. Findings …
Global Clinical Decision Support Systems Market to Reach USD 3.89 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 18, 2025
Delray Beach, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Accelerating adoption of healthcare IT, rising focus on patient safety, and government-backed digital health initiatives reshape global care delivery The global clinical decision support systems (CDSS) …
OncoC4 Strengthens Leadership Team with Appointment of Shiniu Wei as Chief Financial Officer
GlobeNewswire
·
August 18, 2025
ROCKVILLE, Md., Aug. 18, 2025 (GLOBE NEWSWIRE) -- OncoC4, Inc., a late-stage biopharmaceutical company developing novel medicines for cancer today announced the appointment of Shiniu Wei as Chief Financial Officer (CFO). Mr. Wei joins OncoC4 with nearly 20 …